iSpecimen

ISPCNasdaq United States Health Care Biotechnology: Commercial Physical & Biological Resarch

Market cap

$3.380 M

$2.22 +0.91%

Close of 7 Aug 2026

Revenue

$1.93M

#3444 by revenue

Earnings

-$10.5M

Loss-making

Shares outstanding

29,662,250

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Commercial Physical & Biological Resarch — ranked by market cap

All 12 →

#8OmniAbOABI$446.5M
#9MaxcyteMXCT$126.4M
#10OneMedNetONMD$35.6M
#11bioAffinity TechnologiesBIAF$3.97M
#12iSpecimenISPC$3.38M

Where these numbers come from

Share counts and financials for iSpecimen are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.